[go: up one dir, main page]

Spidel et al., 2017 - Google Patents

Site-specific conjugation to native and engineered lysines in human immunoglobulins by microbial transglutaminase

Spidel et al., 2017

Document ID
8899645139829462483
Author
Spidel J
Vaessen B
Albone E
Cheng X
Verdi A
Kline J
Publication year
Publication venue
Bioconjugate Chemistry

External Links

Snippet

The use of microbial transglutaminase (MTG) to produce site-specific antibody–drug conjugates (ADCs) has thus far focused on the transamidation of engineered acyl donor glutamine residues in an antibody based on the hypothesis that the lower specificity of MTG …
Continue reading at pubs.acs.org (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Similar Documents

Publication Publication Date Title
Spidel et al. Site-specific conjugation to native and engineered lysines in human immunoglobulins by microbial transglutaminase
Strop Versatility of microbial transglutaminase
Smith et al. Chemoenzymatic Fc glycosylation via engineered aldehyde tags
Dickgiesser et al. Site-specific conjugation of native antibodies using engineered microbial transglutaminases
Hofer et al. Molecularly defined antibody conjugation through a selenocysteine interface
CN108602878B (en) C-terminal lysine conjugated immunoglobulin
Agarwal et al. Site-specific antibody–drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development
Boeggeman et al. Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection
Marmelstein et al. Tyrosinase-mediated oxidative coupling of tyrosine tags on peptides and proteins
Lizak et al. N-Linked glycosylation of antibody fragments in Escherichia coli
US20210171998A1 (en) Lysine conjugated immunoglobulins
Vila-Perelló et al. Streamlined expressed protein ligation using split inteins
Debon et al. Enzymatic bioconjugation: a perspective from the pharmaceutical industry
Manabe et al. Characterization of antibody products obtained through enzymatic and nonenzymatic glycosylation reactions with a glycan oxazoline and preparation of a homogeneous antibody–drug conjugate via Fc N-glycan
Teufl et al. Engineering strategies to overcome the stability–function trade-off in proteins
Su et al. Custom-designed affinity capture LC-MS F (ab′) 2 assay for biotransformation assessment of site-specific antibody drug conjugates
Chen et al. Stabilizing the CH2 domain of an antibody by engineering in an enhanced aromatic sequon
Zhang et al. General and robust chemoenzymatic method for glycan-mediated site-specific labeling and conjugation of antibodies: facile synthesis of homogeneous antibody–drug conjugates
Grunewald et al. Efficient preparation of site-specific antibody–drug conjugates using phosphopantetheinyl transferases
Hui et al. Optimization of photoactive protein Z for fast and efficient site-specific conjugation of native IgG
Pirzer et al. Generation of potent anti-HER1/2 immunotoxins by protein ligation using split inteins
Hwang et al. Site-specific lysine Arylation as an alternative bioconjugation strategy for chemically programmed antibodies and antibody–drug conjugates
Kotapati et al. Universal affinity capture liquid chromatography-mass spectrometry assay for evaluation of biotransformation of site-specific antibody drug conjugates in preclinical studies
Ou et al. One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody–Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling
Le Gall et al. Dual site-specific chemoenzymatic antibody fragment conjugation using CRISPR-based hybridoma engineering